Enter your login e-mail to the account
Search
Search parameters
Search results
- FOLLICULAR LYMPHOMA
MUDr. Adriana Kafková
(12/2008, Topic )
- ACTUAL MEDICATION OF THE BONE METASTASE
MUDr. Ivan Kolombo, FEBU, MUDr. Martina Poršová, MUDr. Jaroslav Porš, MUDr. Richard Pabišta
(5-6/2007, Review articles ) - CHEMOTHERAPY OF HORMONALLY REFRACTORY PROSTATIC CARCINOMA
doc. MUDr. Jozef Mardiak, CSc.
(2/2007, Review articles )
- Overview of treatment of castration-resistant prostate cancer
MUDr. Jana Obertová
(4/2012, Review articles ) - Systemic treatment of malignant melanoma
MUDr. Iveta Andrezálová Vochyanová
(3/2013, Main topic ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Chemotherapy of hormonally refractory prostatic carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(1/2007, Review articles ) - Capecitabine and its role in the treatment of advanced HER2 positive breast cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2011, Review articles ) - Current treatment options of transplant-ineligible patients with multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(3/2013, Focus ) - Anti-tumor therapy in patients with liver insufficiency
MUDr. Michal Mego, PhD., MUDr. Ján Rajec, PhD.
(1/2011, Review articles ) - CURRENT ALTERNATIVES FOR SECOND LINE CHEMOTHERAPY OF RECURRENT CIS-PLATIN REFRACTORY EPITHELIAL OVARIAN CANCER
MUDr. Radovan Barilla
(2/2006, Review articles ) - Publikujeme v zahraničí
(5/2016, Information & comments ) - Profile of atezolizumab in the treatment of lung cancer
MUDr. Zuzana Pribulová
(2/2024, Drugs & drug classes ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - What is the optimal debalking surgery procedure in patients with advanced ovarian cancer?
MUDr. Ladislav Masák, CSc.
(1/2009, Original articles & case reports ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Immune checkpoint inhibitors in non-small cell lung cancer therapy
MUDr. Mária Černá, CSc.
(6/2015, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Chemotherapy for carcinoma of stomach
MUDr. Tomáš Šálek
(3/2011, Review articles ) - Systemic treatment of breast cancer in pregnancy
MUDr. Oľga Szegheőová
(3/2016, Main topic ) - Neuroendocrine tumors from oncologist's point of view
doc. MUDr. Mária Wagnerová, CSc.
(4/2011, Review articles ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Hypothyroidism – a late adverse effect of radiotherapy in patients with locally advanced head and neck cancers
MUDr. Eva Hajtmanová, PhD., Mgr. Ivana Kinclová, MUDr. Andrej Hajtman, PhD., MUDr. Estera Beháňová, doc. MVDr. Soňa Bálentová, PhD., prof. MUDr. Andrej Hajtman, CSc.
(4/2023, Review articles ) - Therapeutic procedures in the treatment of advanced triple-negative breast cancer – a nationwide survey among selected oncologists from oncology institutes and regional cancer centers in Slovakia
MUDr. Radovan Barila, PhD., MUDr. Elena Marušáková, MBA, Ing. Jan Žigmond
(3/2024, Review articles ) - Multipotent cell-mediated drug resistance
doc. MUDr. Štefan Polák, CSc., Mgr. Lucia Kučerová, PhD., RNDr. Lenka Baranovičová, Mgr. Svetlana Školeková, MUDr. Martin Boháč
(4/2013, Review articles ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMOPOIETIC CELL TRANSPLANTATION
MUDr. Ján Gyárfáš
(5/2008, Review articles ) - New research trends in the tumor cell biology − our research activities
doc. RNDr. Vladimír Zajac, CSc., RNDr. Soňa Čierniková, PhD., RNDr. Ján Sedlák, DrSc., Mgr. Lucia Kučerová, PhD., RNDr. Miroslava Matúšková, PhD., Mgr. Erika Ďuriníková, RNDr. Katarína Szabová, PhD
(1/2015, Main topic ) - Použitie rastových faktorov myelopoézy v profylaxii febrilnej neutropénie
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Ľubica Váleková, PhD., Prof. MUDr. Ján Staško, PhD.
(2/2018, Review articles ) - Cardiotoxicity of drugs used in adjuvant therapy of breast cancer
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Katarína Ševčíková
(2/2009, Review articles ) - Malignant peritoneal mesothelioma
MUDr. Karel Kroupa, PhD.
(1/2015, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Zriedkavý nádor hrudníka: malígny pleurálny mezotelióm
MUDr. Lucia Denková, MUDr. František Sándor, PhD., FCCP
(3/2018, Main topic ) - Olaratumab – liečba pre pacientov s pokročilým sarkómom mäkkých tkanív nevhodných na chirurgickú liečbu alebo rádioterapiu
MUDr. Peter Zuzák
(3/2018, Drugs & drug classes ) - Systemic treatment of advanced, persistent or recurrent cervical cancer
MUDr. Mária Rečková
(4/2015, Review articles ) - Lipegfilgrastim − new drug form similar to filgrastim in treatment of neutropenia of oncologic patients
prof. PharmDr. Ján Kyselovič, CSc., PharmDr. Andrea Gažová, PhD.
(4/2015, Drugs & drug classes ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - Current possibilities of immunotherapy in the treatment of malignant melanoma
MUDr. Iveta Andrezálová Vochyanová
(4/2016, Main topic ) - Správa z podujatia ASCO Chicago 2012
(3/2012, Events ) - Publikujeme v zahraničí
(1/2016, Information & comments ) - Antitumor immunity
MUDr. Ján Lakota, CSc., MUDr. Milan Žuffa, CSc.
(2/2015, Review articles ) - Current situation in the systemic therapy of liver tumours
MUDr. Tomáš Šálek
(4/2010, Review articles ) - Treatment of germinal tumor during the COVID-19 pandemic
MUDr. Miriam Hančinová, MUDr. Peter Zuzák, prof. MUDr. Dalibor Ondruš, DrSc., MUDr. Bela Mriňáková, PhD., MPH
(3/2022, Main topic ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - Chemotherapy and imunotherapy for malignant melanoma
MUDr. Slavomír Urbanček, PhD.
(3/2009, Review articles ) - Pancreatic and biliary cancer
MUDr. Filip Kohútek, PhD., MUDr. Tomáš Sedláček, MUDr. Branislav Bystrický, PhD., MPH
(1/2018, Review articles ) - CENTRAL NERVOUS SYSTEM INVOLVEMENT IN HEMATOLOGICAL MALIGNANCIES
doc. MUDr. Martin Mistrík, PhD.
(3/2007, Review articles - treatment ) - Hepatitis B in the cancer patients treated by chemotherapy
MUDr. Tomáš Šálek, doc. MUDr. Peter Jarčuška, PhD., MUDr. Sylvia Dražilová, MUDr. Marian Oltman, MUDr. Ľubomír Skladaný
(6/2011, Review articles )